Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis

Multiple sclerosis (MS) is a chronic progressive disorder of the CNS that leads to neurodegeneration and accumulation of neurologic disability. At disease onset, it is challenging to predict whether individual patients will have a benign or aggressive disease course, and whether individual patients will respond to disease-modifying therapies. MS phenotypes1 and diagnostic criteria2 are defined on the basis of clinical and MRI characteristics. They are limited in their ability to guide treatment decisions.

Source link

Related posts

As CBD Finds Small-town America, What Do We Tell Its Graying Users?


Perfusion abnormality on three-dimensional arterial spin labeling with a 3T MR system in pediatric and adolescent patients with migraine


Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy